Last updated on July 2020

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Brief description of study

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weight. The study has two phases: A main phase and an extension phase. The main phase of the study will last 72 weeks (14 visits). Participants with prediabetes will continue in the extension for another 2 years.

Clinical Study Identifier: NCT04184622

Find a site near you

Start Over

OCROM Clinic

Suita, Japan
  Connect »

AMC nishi-umeda clinic

Osaka, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.